The government will soon announce the first 10 medications that will be subject to price negotiations with Medicare under a new law. Drugmakers are fighting the measure in court.
Read More Inflation Reduction Act of 2022, Medicare, Drugs (Pharmaceuticals), Prices (Fares, Fees and Rates), Suits and Litigation (Civil), Health Insurance and Managed Care, Bristol Myers Squibb Company, Merck & Company Inc, Johnson & Johnson, Astellas Pharma, Pharmaceutical Research and Manufacturers of America, United States Chamber of Commerce, Biden, Joseph R Jr, Centers for Medicare and Medicaid Services, Health and Human Services Department, Law and Legislation, United States Politics and Government
